Study Condition(s): Parkinson's Disease

A Study of LY3154207 in Participants With Parkinson's Disease (Part B)

Study Alias: HBEC

Study Identifier(s): Tool Tip Icon {{ defaultRegistry.registryAnchorText }} NCT02562768 {{ currentLocaleObject.registryAnchorText }}

Completed Completed

Study Purpose

The purpose of part B of this study will evaluate how safe LY3154207 is and the effect it has on the body.

Completed Study

The results of this study are not yet available.

Who Participated? Tool Tip Icon

Here you can find out a bit more about the requirements for volunteers who took part in this study


Male Female


20+ years

Time Commitment

Your participation could last up to 49 weeks including a 17 day stay in the clinical research unit (CRU) and follow-up.
  • Part B participant must have a clinical diagnosis of Parkinson's disease for at least 1 year and be on stable medication for at least 4 weeks

  • Part B participant must be reliable and willing to make themselves available for the duration of the study and are willing to follow study procedures

  • Part B participant must not have participated in a clinical trial involving an investigational product within the last 30 days

  • Part B participant must provide written informed consent

Where This Study Took Place Tool Tip Icon

2 locations participated
Invalid Postal Code.
Please re-enter postal code.

{{sites.getPageStartCount()}} - {{sites.getPageEndCount()}} of {{sites.totalCount}} Results

0 of {{sites.totalCount}} Results

Distance Location
{{site.getDistance() | number:0}} {{convertUnit("imperial", "mile") | translate}} {{convertUnit("imperial", "miles") | translate}}
Closest Location
{{site.getDistance() | number:0}} {{convertUnit("imperial", "mile") | translate}} {{convertUnit("imperial", "miles") | translate}}
Other Location(s)
{{site.getDistance() | number:0}} {{convertUnit("imperial", "mile") | translate}} {{convertUnit("imperial", "miles") | translate}}

To improve your experience on Lilly TrialGuide, please use the latest version of Chrome, Firefox, Safari, or Internet Explorer, with Java Script enabled.
This website is not optimized for your browser, as configured.